Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York
- PMID: 6734291
- DOI: 10.1378/chest.86.1.44
Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York
Abstract
The Memorial Sloan-Kettering lung cancer screening program was begun in 1974 to evaluate sputum cytology as a supplement to the annual chest x-ray examination for early detection and diagnosis. The 10,040 adult, male cigarette smokers who enrolled were randomly assigned to receive annual chest x-ray examinations only or a dual screen with annual chest x-ray examination and four monthly sputum cytology evaluation. Over 40 percent of the 288 who developed lung cancer were diagnosed in stage I, and their survival was 76 percent at five years; overall survival was 35 percent. Nearly one third of the lung cancers detected on first examination on the dual screen, and 14 percent of those on subsequent examinations were found by cytologic examination. The same number of cancers developed in the x-ray screen only group, and were diagnosed at a later date. Despite the delay, survival and mortality were the same, suggesting that the squamous carcinomas detected by cytologic examination alone are very slow growing and tend to remain localized until detectable by x-ray examination.
Similar articles
-
Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.Cancer. 2009 Nov 1;115(21):5007-17. doi: 10.1002/cncr.24545. Cancer. 2009. PMID: 19637354 Free PMC article. Clinical Trial.
-
The early diagnosis of lung cancer.Dis Mon. 2001 Jun;47(6):204-64. doi: 10.1067/mcd.2001.116285. Dis Mon. 2001. PMID: 11473242 Review.
-
Lung cancer screening results in the National Cancer Institute New York study.Cancer. 2000 Dec 1;89(11 Suppl):2356-62. doi: 10.1002/1097-0142(20001201)89:11+<2356::aid-cncr8>3.3.co;2-q. Cancer. 2000. PMID: 11147612 Clinical Trial.
-
Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening.Chest. 1995 Jun;107(6 Suppl):270S-279S. doi: 10.1378/chest.107.6_supplement.270s. Chest. 1995. PMID: 7781405 Review.
-
Detection of lung cancer: highlights of the Memorial Sloan-Kettering Study in New York City.Schweiz Med Wochenschr. 1987 Sep 26;117(39):1457-63. Schweiz Med Wochenschr. 1987. PMID: 2823375 Clinical Trial.
Cited by
-
Implementing physician education to increase lung cancer screening uptake.Lung Cancer Manag. 2023 Apr 25;11(2):LMT55. doi: 10.2217/lmt-2022-0008. eCollection 2023 Feb. Lung Cancer Manag. 2023. PMID: 37122495 Free PMC article.
-
Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future.Diagnostics (Basel). 2022 Oct 31;12(11):2644. doi: 10.3390/diagnostics12112644. Diagnostics (Basel). 2022. PMID: 36359485 Free PMC article. Review.
-
The 50-Year Journey of Lung Cancer Screening: A Narrative Review.Cureus. 2022 Sep 20;14(9):e29381. doi: 10.7759/cureus.29381. eCollection 2022 Sep. Cureus. 2022. PMID: 36304365 Free PMC article. Review.
-
Advances in lung cancer screening and early detection.Cancer Biol Med. 2022 May 11;19(5):591-608. doi: 10.20892/j.issn.2095-3941.2021.0690. Online ahead of print. Cancer Biol Med. 2022. PMID: 35535966 Free PMC article. Review.
-
Lung Cancer Screening: Review and 2021 Update.Curr Pulmonol Rep. 2022;11(1):15-28. doi: 10.1007/s13665-021-00283-1. Epub 2022 Apr 2. Curr Pulmonol Rep. 2022. PMID: 35402145 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical